Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Trade Agreements: USA

Department for International Trade written question – answered on 9th March 2020.

Alert me about debates like this

Photo of Patrick Grady Patrick Grady SNP Chief Whip

To ask the Secretary of State for International Trade, what assessment she has made of the potential merits of protecting regulatory data exclusivity for innovative drugs in a UK-US trade deal.

Photo of Greg Hands Greg Hands The Minister of State, Department for International Trade

The Government’s objectives for US negotiations state that we will secure provisions that protect the UK’s world-leading intellectual property standards and seek an effective and balanced regime which supports innovation within the pharmaceutical sector, while reflecting wider public interests such as ensuring patient access to medicines.

The Government is clear that when negotiating free trade agreements, the NHS and the price the NHS pays for medicines will not be on the table. We will not agree to measures which undermine the Government’s ability to deliver our NHS manifesto commitments.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.